Distribution of several activating and inhibitory receptors on CD3 -CD56+ NK cells in regional lymph nodes of melanoma patients

Journal of Surgical Research

Volumn 183, Issue 2, 2013, Pages 860-868

  Vuletić, Ana ^a   Jurišić, Vladimir ^b   Jovanić, Irena ^a   Milovanović, Zorka ^a   Nikolić, Srdan ^a   Konjević, Gordana ^a,c  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^b UNIVERSITY OF KRAGUJEVAC   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

CD16; KIR; Lymph nodes; Melanoma; NK cell receptors; NK cells; NKG2D

Indexed keywords

ANTIGEN; CD158B ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; NATURAL KILLER CELL RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPH NODE; MALE; MELANOMA; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CD16; KIR; LYMPH NODES; MELANOMA; NK CELL RECEPTORS; NK CELLS; NKG2D;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; ANTIGENS, CD56; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, IGG; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL3; RECEPTORS, NATURAL KILLER CELL; SKIN NEOPLASMS;

EID: 84880307201     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.02.025     Document Type: Article

References (39)

1. W.C. Sumner, and A.G. Foraker Spontaneous regression of human melanoma: clinical and experimental studies Cancer 13 1960 79
2. R. Kiessling, E. Klein, and H. Wigzell Natural killer cells in the mouse. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype I Eur J Immunol 5 1975 112
3. G. Trinchieri Biology of natural killer cells Adv Immunol 47 1989 187
4. C.A. Biron, K.B. Nguyen, and G.C. Pien Natural killer cells in antiviral defense: function and regulation by innate cytokines Annu Rev Immunol 17 1999 189
5. M.J. Robertson, and J. Ritz Biology and relevance of human natural killer cells Blood 76 1990 2421
6. M.A. Cooper, T.A. Fehniger, and M.A. Caligiuri The biology of human natural killer-cell subsets Trends Immunol 22 2001 633
7. G. Ferlazzo, D. Thomas, and S.L. Lin The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic J Immunol 172 2004 1455
8. L.L. Lanier Natural killer cell receptor signaling Curr Opin Immunol 15 2003 308
9. S.S. Farag, and M.A. Caligiuri Human natural killer cell development and biology Blood Rev 20 2006 123
10. N. Nausch, and A. Cerwenka NKG2D ligands in tumor immunity Oncogene 27 2008 5944
11. A. Nagler, L.L. Lanier, and S. Cwirla Comparative studies of human FcRIII-positive and negative natural killer cells J Immunol 143 1989 3183
12. O. Mandelboim, P. Malik, and D.M. Davis Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity Proc Natl Acad Sci U S A 96 1999 5640
13. L.L. Lanier, A.M. Le, and C.I. Civin The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes J Immunol 136 1986 4480
14. H.S. Warren, and B.F. Kinnear Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation J Immunol 162 1999 735
15. M. Uhrberg, N.M. Valiante, and B.P. Shum Human diversity in killer cell inhibitory receptor genes Immunity 7 1997 753
16. J. Trowsdale, and P. Parham Mini-review: defense strategies and immunity-related genes Eur J Immunol 34 2004 7
17. M. Yawata, N. Yawata, and M. Draghi Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function J Exp Med 203 2006 633
18. J.J. Campbell, S. Qin, and D. Unutmaz Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire J Immunol 166 2001 6477
19. A.G. Freud, B. Becknell, and S. Roychowdhury A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells Immunity 22 2005 295
20. A.G. Freud, and M.A. Caligiuri Human natural killer cell development Immunol Rev 214 2006 56
21. T.A. Fehniger, M.A. Cooper, and G.J. Nuovo CD56 bright natural killer cells are present in human lymph nodes and are activated by T cell - derived IL-2: a potential new link between adaptive and innate immunity Immunity 101 2003 3052
22. G. Konjevic, K. Mirjacic Martinovic, and A. Vuletic Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients Clin Exp Metastasis 24 2007 1
23. E. Naumova, A. Mihaylova, and M. Ivanova Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma Cancer Immunol Immunother 56 2007 95
24. E. Mamessier, A. Sylvain, and M.L. Thibult Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity J Clin Invest 121 2011 3609
25. Z. Farzad, A.J. Cochran, and W.H. McBride Lymphocyte subset alterations in nodes regional to human melanoma Cancer Res 50 1990 3585
26. B.A. Morton, W.G. Ramey, and H. Paderon Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer Cancer Res 4 Pt 2 1986 2121
27. P. Carrega, B. Morandi, and R. Costa Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells Cancer 112 2008 863
28. J.S. Schleypen, N. Baur, and R. Kammerer Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma Clin Cancer Res 12 2006 718
29. A. Martín-Fontecha, L.L. Thomsen, and S. Brett Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming Nat Immunol 5 2004 1260
30. C. Romagnani, K. Juelke, and M. Falco CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation J Immunol 178 2007 4947
31. A. Chan, D.L. Hong, and A. Atzberger CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts J Immunol 179 2007 89
32. M. Balsamo, F. Scordamaglia, and G. Pietra Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity Proc Natl Acad Sci U S A 106 2009 20847
33. Y.T. Bryceson, M.E. March, and H.G. Ljunggren Activation, coactivation, and costimulation of resting human natural killer cells Immunol Rev 214 2006 73
34. M. Campoli, and S. Ferrone Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands Tissue Antigens 72 2008 321
35. Y.T. Bryceson, M.E. March, and H.G. Ljunggren Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion Blood 107 2006 159
36. T. Rodriguez, R. Mendez, and C.H. Roberts High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity Cancer Immunol Immunother 54 2005 141
37. M. Campoli, and S. Ferrone HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition Semin Immunopathol 33 2011 321
38. P. Carrega, G. Pezzino, and P. Queirolo Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells PLoS One 4 2009 e8132
39. F. Borrego, M.J. Robertson, J. Ritz, J. Peña, and R. Solana CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor Immunology 97 1999 159